25 results on '"van Laar, Teus"'
Search Results
2. Postural and gait symptoms in de novo Parkinson's disease patients correlate with cholinergic white matter pathology
3. Enhanced arm swing improves Parkinsonian gait with EEG power modulations resembling healthy gait
4. Long-term safety and efficacy of apomorphine infusion in Parkinson's disease patients with persistent motor fluctuations: Results of the open-label phase of the TOLEDO study
5. Retinal layers in Parkinson's disease: A meta-analysis of spectral-domain optical coherence tomography studies
6. Apomorphine subcutaneous infusion in patients with Parkinson's disease with persistent motor fluctuations (TOLEDO): a multicentre, double-blind, randomised, placebo-controlled trial
7. Continuous subcutaneous apomorphine infusion in Parkinson's disease patients with cognitive dysfunction: A retrospective long-term follow-up study
8. Short-latency afferent inhibition as a biomarker of cholinergic degeneration compared to PET imaging in Parkinson's disease
9. Cognitive and psychiatric outcome 3 years after globus pallidus pars interna or subthalamic nucleus deep brain stimulation for Parkinson's disease
10. Unmet needs in Parkinson's disease: New horizons in a changing landscape
11. The need for non-oral therapy in Parkinson's disease; a potential role for apomorphine
12. Understanding the role of the Parkinson's disease nurse specialist in the delivery of apomorphine therapy
13. Parkinson's disease, visual hallucinations and apomorphine: A review of the available evidence
14. Motor and non-motor outcomes of continuous apomorphine infusion in 125 Parkinson's disease patients
15. Expert Consensus Group report on the use of apomorphine in the treatment of Parkinson's disease – Clinical practice recommendations
16. Occupational exposure to solvents, metals and welding fumes and risk of Parkinson's disease
17. Early factors for predicting discontinuation to subcutaneous Apomorphine infusion in Parkinson's disease: A prospective analysis of the Thai Apomorphine Registry
18. Treatment of subcutaneous nodules after infusion of apomorphine; a biopsy-controlled study comparing 4 frequently used therapies
19. Attentional and perceptual impairments in Parkinson's disease with visual hallucinations
20. Oscillatory activity and cortical coherence of the nucleus basalis of Meynert in Parkinson's disease dementia
21. Letter to the editor, “Validation and clinical value of the MANAGE-PD tool: A clinician-reported tool to identify Parkinson's disease patients inadequately controlled on oral medications”
22. Effect of pharmacist-led interventions on motor symptoms in Parkinson's patients: A pilot study
23. Effect of pharmacist-led interventions on motor symptoms in Parkinson's patients: A pilot study
24. Continuous subcutaneous infusion of apomorphine can be used safely in patients with Parkinson's disease and pre-existing visual hallucinations
25. 1.IS.3. On-going developments in the use of apomorphine in complex Parkinson's disease (Britannia Pharmaceuticals Ltd.)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.